StemCell Therapy

Dublin, Dec. 23, 2019 (GLOBE NEWSWIRE) -- The "Asia-Pacific 3D Cell Culture Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Research conducted shows the 3D cell culture market in the Asia-Pacific would be fast progressing in terms of revenue, with a CAGR of 13.11% over the forecasting years 2019-2027.

India, Japan, China, South Korea, Australia & New Zealand, ASEAN countries and Rest of APAC countries together constitute the Asia-Pacific 3D cell culture market.

Several R&D projects are being initiated in South Korea to cater to the rising demand for stem cell therapies and regenerative medicine. In September 2017, the Cell Therapy World Asia 2017 was held in the country. Several cell therapy companies in Asia gathered for the conference to discuss the best practices & innovations in this field. Such factors are promoting the growth of the South Korean 3D cell culture market.

It has been anticipated that the 3D cell culture market in Japan would witness growth, owing to the country releasing new products in the market. Pluristem Therapeutics received a patent for their technology of using 3D cell culturing methods, that allow the creation of cell therapies from fat cells.

The Government of Japan has been focusing increasingly on Cell-based regenerative medicine, which indicates further advances in 3D cell culture technology over the projected period. In 2014, Japan-based Reprocell acquired Reinnervate Ltd., a spin-off of Durham University, agreeing to invest in the researches conducted in the university laboratories for scaffolding structures that support the growth of 3D cells.

COMPETITIVE OUTLOOK

The biggest brands in the 3D cell culture market are Merck KGaA, 3D Biotek, LLC, Thermo Fisher Scientific, Inc., Corning Inc., InSphero, Lonza Group AG, and Synthecon, Incorporated.

Key Topics Covered

1. Asia-Pacific 3D Cell Culture Market - Summary

2. Industry Outlook

2.1. Market Definition2.2. Porter'S Five Forces Model2.2.1. Threat Of New Entrants2.2.2. Threat Of Substitute2.2.3. Bargaining Power Of Buyers2.2.4. Bargaining Power Of Suppliers2.2.5. Threat Of Competitive Rivalry2.3. Economic Technological, And Political & Legal Outlook2.4. Regulatory Outlook2.5. Key Insight2.6. Market Attractiveness Index2.7. Market Drivers2.7.1. Growing Cancer Prevalence2.7.2. High Demand For Organ Transplantation2.7.3. Promising Developments Using Regenerative Medicine2.8. Market Restraints2.8.1. Lack Of Skilled Professionals2.8.2. Incompatibilities Of The Preferred Analytical Technologies With 3D Cell Culture2.9. Market Opportunities2.9.1. Increasing Usage Of 3D Cell Culture In Organ Transplantation And Drug Screening2.9.2. Technological Advancement2.10. Market Challenges2.10.1. Lack Of Availability Of Data For Research On 3D Cell Culture2.10.2. Challenges Associated With 3D Cell Culture In Performing Experiments

3. 3D Cell Culture Market Outlook - By Technology

3.1. Scaffold-Based3.1.1. Hydrogels3.1.2. Polymeric Scaffolds3.1.3. Micropatterned Surface Microplates3.2. Scaffold-Free3.2.1. Hanging Drop Microplates3.2.2. Spheroid Microplates Containing Ultra-Low Attachment (Ula) Coating3.2.3. Microfluidic 3D Cell Culture3.2.4. Magnetic Levitations & 3D Bioprinting3.3. 3D Bioreactors

4. 3D Cell Culture Market Outlook - By Application

4.1. Cancer4.2. Tissue Engineering & Immunohistochemistry4.3. Drug Development4.4. Stem Cell Research4.5. Other Applications

5. 3D Cell Culture Market Outlook - By Component

5.1. Media5.2. Reagents And Consumables

6. 3D Cell Culture Market Outlook - By End-User

6.1. Biotechnology And Pharmaceutical Organizations6.2. Research Laboratories And Institutes6.3. Hospitals And Diagnostic Centers6.4. Other End-Users

7. 3D Cell Culture Market - Regional Outlook

7.1. Asia-Pacific7.1.1. Country Analysis7.1.1.1. Japan7.1.1.2. China7.1.1.3. India7.1.1.4. Australia & New Zealand7.1.1.5. South Korea7.1.1.6. Asean Countries7.1.1.7. Rest Of Asia-Pacific

8. Company Profiles

8.1. Becton Dickinson And Company8.2. Tecan Group Ltd.8.3. Promocell Gmbh8.4. Corning Inc.8.5. Nano3D Biosciences, Inc.8.6. 3D Biotek, Llc8.7. Merck Kgaa8.8. Emulate8.9. Thermo Fisher Scientific, Inc.8.10. Ge Healthcare8.11. Insphero8.12. Lonza Group Ag8.13. Vwr Corporation8.14. Synthecon, Incorporated

Story continues

For more information about this report visit https://www.researchandmarkets.com/r/reo3ym

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Excerpt from:
Study of the 3D Cell Culture Market in Asia-Pacific, 2019-2027: Projecting a 13.11% CAGR, Driven by Promising Developments Using Regenerative Medicine...

This entry was posted on December 23, 2019 at 5:47 pm and is filed under Fat Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |